Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Baseline Liquid Biopsy Results in 1L Treatment Efficacy of FOLFIRI/Cetuximab in Pts With Tissue RAS-WT mCRC"

859 views
June 15, 2023
0 Comments
Login to view comments. Click here to Login
GI